A NSW Government website

On

Neurology Research

Our Research Team

Associate Professor Rebekah Ahmed

Associate Professor, Brain and Mind Centre

Staff Specialist Neurologist, Royal Prince Alfred Hospital

Professor Craig Anderson

Professor of Neurology and Epidemiology, Faculty of Medicine, UNSW Sydney

Neurologist, Royal Prince Alfred Hospital

Professor Michael Barnett
MBBS (Hons), FRACP, FRCP, PhD

Consultant Neurologist, Royal Prince Alfred Hospital

Senior Academic, University of Sydney

Director, RPA Muscular Sclerosis Clinic and Muscular Sclerosis Clinical Trials Unit, Brain and Mind Centre

Co-director, MS Research Australia Brain Bank

Professor G. Michael Halmagyi

Consultant Neurologist, Royal Prince Alfred Hospital

Professor of Neurology, University of Sydney

Professor Matthew Kiernan AM
MBBS (Hons) (USYD), PhD (UNSW), DSc (UNSW), FRACP, FAHMS, FAA

Bushell Professor of Neurology, University of Sydney, Brain and Mind Centre and Royal Prince Alfred Hospital

Co -Director, Brain and Mind Centre – Discovery and Translation

Associate Professor Armin (Mohamed) Nikpour
MBBS (Hons), FRACP, BSc (Math)
Director, Comprehensive Epilepsy Service, Royal Prince Alfred Hospital and University of Sydney
Associate Professor Miriam Welgampola
BSc Med (Hon), FRACP, PhD

Consultant Neurologist, Royal Prince Alfred Hospital

Associate Professor of Neurology, University of Sydney

Associate Professor John Worthington Director, Comprehensive Stroke Service, Royal Prince Alfred Hospital

Selected Grants

Amount awarded Grant and project details
$24,025,090 NHMRC, 2019-2024
Clinical, public health and policy interventions to combat cardiovascular diseases
Investigators: Neal B, Patel A, Anderson C,  Woodward M, Rodgers A, Perkovic V, Chalmers J, Chow C, Lindley R, Jan S
£2,000,000.00  MRC (UK), 2020-2023
The third, intensive care bundle with blood pressure reduction in acute cerebral haemorrhage (INTERACT 3) trial
Investigator: Anderson CS
$3,711,898 NHMRC, 2023-2026
INTErGenerational intervention to Reduce fraIlTY trial (INTEGRITY).
Investigators: Peters R, Rockwood K, Fitzgerald J, Delbaere K, Ward S, Anderson C, Kimonis E, Hubbard R, Kurrle S, Janda M.
$3,000,000 NHMRC, 2022-2027
NHMRC Centre of Research Excellence in Enhanced Dementia Diagnosis (CREEDD). 
Investigators: Ayton S, Brodtman A, Bush A, Ayton D, Bammer R, Lim Y, Wooward M, Ahmed RM, Ahern S, Liew D.
$2,927,077 MRFF, 2023-2026
AIS-SHIELDS: Securing Health Intelligence Efforts & Linking Data Silos.
Investigators: Sullivan R, Barnett MH, Wang CT.
$2,795,200 NHMRC, 2021-2026
Clinical trial to determine the effects of statins on cognition: STAREE-Mind
Investigators: Ryan J, Zoungas S, Anderson C, Law M, Chong T, Harding I, Heritier S, Naismith S, O’Sullivan M, Liew D
$2,758,598 NHMRC, 2020-2024
Extending the time window for Tenecteplase by Effective Reperfusion of peNumbrAL tissue in patients with Large Vessel Occlusion (ETERNAL)
Investigators: Parsons M, Butcher K, Campbell B, Churilov L, Davis S, Anderson CS, Moodie M, Levi C, Markus H, Coutts S
$2,706,533 MRFF, 2021-2024
Safety and Tolerability of AZD6482 in Reperfusion for Stroke (STARS)
Investigators: Jackson S, Delcourt C, Anderson C, Di Tanna GL, Schoenwaelder S, Ang T
$2,375,779 MRFF, 2021-2023
Statin Treatment for COVID-19 to optimise Neurological Recovery (STRONGER) trial
Investigators: Anderson, CS
$2,029,361 MRFF, 2022-2025
Enhanced Control of Hypertension and Thrombectomy Stroke Study (ENCHANTED-MT).
Investigators: Anderson C, Song L, Chen X, Parsons M, Wang X, Butcher K, Campbell B.
$2,000,000 MRFF, 2024-2028
A new tool to optimise the early and accurate diagnosis of frontotemporal dementia.
Investigators: Irish M, Ahmed R, Piguet P, Kumfor F.
$1,999,835 MRFF, 2024-2029
Fludrocortisone in ICU patients with aneurysmal subarachnoid haemorrhage.
Investigators: Cohen J, Anderson CS, Belapart J, Burrell L, Delaney A, Jeffree R, Li Q, Talbot P, Udy A, Young M.
$1,995,481 NHMRC, 2019-2023
Translating the evidence on dementia risk reduction to generate assessments, advice and training for health professionals, policy makers, patients and public.
Investigators: Anstey K, Peters R, Lautenschlager N, Shaw J, Anderson C, Jorm L, Kiely K, Whitmer R, Matthews F, Kivipelto M
$1,774,988 MRFF, 2022-2025
Optimal Post rTPA-iv Monitoring in Ischaemic Stroke (OPTIMISTmain) clinical trial.
Investigators: Anderson CS.
$1,700,000 MRFF, 2020-2023
ALS Trials Australia (ALSTA) – to develop precision medicine.
Investigators: Kiernan MC, Vucic S, Wray N, Talman P, Needham M, Schultz D, Barnett M, Park S.
$1,604,184 MRFF - Rare Cancers, Rare Diseases and Unmet Need (RCRDUN), 2020-2023
Evaluating the effectiveness and safety of sodium selenate as a disease modifying treatment for patients with behavioural variant Frontotemporal Dementia (bvFTD)
Investigators: Piguet O, O'Brien T, Malpas C, Velakoulis D, Brodtmann A, Kalincik T, Walterfang M, Ahmed R, Bush A, Darby D
$1,600,000 NHMRC, 2019-2023
Motor Neurone Disease: Patient centred care for a progressive neurological disease - evidence driving policy
Investigators: Kiernan MC, Wray N, Talman P, Vucic S, Mathers S, Henderson R, Bellgard M, Aoun S, Savulescu J, Rowe D
$1,535,099 NHMRC, 2024-2029
ACT-GLOBAL platform trial to resolve uncertainty over thrombolysis treatment in acute ischaemic stroke.
Investigators: Anderson CS, Chen X, Menon B, Hill M, Campbell B, Parsons MW, Demchuk A, Sandset EC, Saver J, Sylaja PN.
$1,401,595 NHMRC, 2020-2024
Generating new evidence & improving health systems to improve the management of stroke across the globe
Investigators: Anderson CS
$1,400,000 Nerve Research Foundation, 2020-2023
MSBase Imaging Repository.
Investigators: Barnett MH.
$999,632 MRFF, 2022-2025
Non-invasive imaging of atherosclerotic plaque: quantification of disease activity for improved identification of patients with residual cardiovascular risk.
Investigators: Blair C
$822,196 NHMRC, 2018-2023
Motor Neurone Disease: Patient centred care for a progressive neurological disease - evidence driving policy.
Investigators: Kiernan MC.
$771,042 NHMRC/Partnership Project for Better Health, 2018-2023
Motor Neurone Disease: Patient centred care for a progressive neurological disease - evidence driving policy
Investigators: Kiernan M
$600,000 NHMRC DCRC, 2020-2024
World Class Research grant. Frontotemporal Dementia or Autism spectrum disorder
Investigators: Piguet O, Gustella A, Kumfor F, Ahmed RM
$585,270 NHMRC Practitioner Fellowships, 2019-2023
Developing new therapies for neurodegeneration and dementia
Investigators: Kiernan M.
$530,000 Fight MND Research Grant, 2022-2025
Multi-arm, Adaptive, Group sequential trial NETwork to evaluate drug efficacy in patients with MND (MAGNET).
Investigators: Kiernan MC.

Our Publications

2023

Argaet EC, Kwok BYC, Bradley J, Young AS, Nham B, Calic Z, Taylor RL, Pogson JM, Reid N, Kong JHK, Flanagan S, Halmagyi GM, Rosengren SM, Welgampola MS. Subjective visual horizontal correlates better with ocular than with cervical vestibular evoked myogenic potentials. Clin Neurophysiol. 2023 Aug;152:1-10. doi: 10.1016/j.clinph.2023.04.011. Epub 2023 May 12.
Banzrai C, Bosookhuu O, Yadamsuren E, Dambasuren B, Turbat S, Erdenedalai T, Myadagsuren M, Munkhtur U, Baatar K, Boldbayar P, Avirmed T, Badrakh B, Ouyang M, Chen X, Wang X, Anderson CS. Incidence and outcomes for stroke in Ulaanbaatar, Mongolia, during 2019-21: a prospective population-based study. Lancet Glob Health. 2023 Jun;11(6):e942-e952. doi: 10.1016/S2214-109X(23)00130-4. Epub 2023 Apr 26.
Barnett M, Wang D, Beadnall H, Bischof A, Brunacci D, Butzkueven H, Brown JWL, Cabezas M, Das T, Dugal T, Guilfoyle D, Klistorner A, Krieger S, Kyle K, Ly L, Masters L, Shieh A, Tang Z, van der Walt A, Ward K, Wiendl H, Zhan G, Zivadinov R, Barnett Y, Wang C. A real-world clinical validation for AI-based MRI monitoring in multiple sclerosis. NPJ Digit Med. 2023 Oct 19;6(1):196. doi: 10.1038/s41746-023-00940-6.
Bhatia KD, Chowdhury S, Andrews I, Goetti R, Webster R, Troedson C, Dale RC, Muthusami P, Parra-Farinas C, Dlamini N, Moharir M, Miteff C, Miteff F, Worthington J, Tastula K, Ang T, Briest R, Pulcine E. Association Between Thrombectomy and Functional Outcomes in Pediatric Patients With Acute Ischemic Stroke From Large Vessel Occlusion. JAMA Neurol. 2023 Sep 1;80(9):910-918. doi: 10.1001/jamaneurol.2023.2303. Erratum in: JAMA Neurol. 2023 Sep 1;80(9):1004. doi: 10.1001/jamaneurol.2023.3292.
Carcel C, Haghdoost F, Shen J, Nanda P, Bai Y, Atkins E, Torii-Yoshimura T, Clough AJ, Davies L, Cordato D, Griffiths LR, Balicki G, Wang X, Vidyasagar K, Malavera A, Anderson CS, Zagami AS, Delcourt C, Rodgers A. The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis. Cephalalgia. 2023 Jun;43(6):3331024231183166. doi: 10.1177/03331024231183166.
Chen C, Lin Y, Liu F, Chen X, Billot L, Li Q, Guo Y, Liu H, Si L, Ouyang M, Zhang C, Arima H, Bath PM, Ford GA, Robinson T, Sandset EC, Saver JL, Sprigg N, van der Worp HB, Liu G, Song L, Yang J, Li G, Anderson CS; INTERACT4 Investigators. Update on the INTEnsive ambulance-delivered blood pressure Reduction in hyper-ACute stroke Trial (INTERACT4): progress and baseline features in 2053 participants. Trials. 2023 Dec 20;24(1):817. doi: 10.1186/s13063-023-07861-5.
Chen C, Ouyang M, Ong S, Zhang L, Zhang G, Delcourt C, Mair G, Liu L, Billot L, Li Q, Chen X, Parsons M, Broderick JP, Demchuk AM, Bath PM, Donnan GA, Levi C, Chalmers J, Lindley RI, Martins SO, Pontes-Neto OM, Venturelli PM, Olavarría V, Lavados P, Robinson TG, Wardlaw JM, Li G, Wang X, Song L, Anderson CS. Effects of intensive blood pressure lowering on cerebral ischaemia in thrombolysed patients: insights from the ENCHANTED trial. EClinicalMedicine. 2023 Feb 15;57:101849. doi: 10.1016/j.eclinm.2023.101849.
Clarke AJ, Manser D, Fleischer R, Fulham M, Ahmed RM. Pearls & Oy-sters: Huntington Disease Presenting as Primary Progressive Aphasia: A Case of Semantics. Neurology. 2023 Aug 29;101(9):414-417. doi: 10.1212/WNL.0000000000207428. Epub 2023 May 18.
Cochrane A, Chen C, Stephen J, Rønning OM, Anderson CS, Hankey GJ, Al-Shahi Salman R. Antithrombotic treatment after stroke due to intracerebral haemorrhage. Cochrane Database Syst Rev. 2023 Jan 26;1(1):CD012144. doi: 10.1002/14651858.CD012144.pub3.
Daruwalla C, Shaygannejad V, Ozakbas S, Havrdova EK, Horakova D, Alroughani R, Boz C, Patti F, Onofrj M, Lugaresi A, Eichau S, Girard M, Prat A, Duquette P, Yamout B, Khoury SJ, Sajedi SA, Turkoglu R, Altintas A, Skibina O, Buzzard K, Grammond P, Karabudak R, van der Walt A, Butzkueven H, Maimone D, Lechner-Scott J, Soysal A, John N, Prevost J, Spitaleri D, Ramo-Tello C, Gerlach O, Iuliano G, Foschi M, Ampapa R, van Pesch V, Barnett M, Shalaby N, D'hooghe M, Kuhle J, Sa MJ, Fabis-Pedrini M, Kermode A, Mrabet S, Gouider R, Hodgkinson S, Laureys G, Van Hijfte L, Macdonell R, Oreja-Guevara C, Cristiano E, McCombe P, Sanchez-Menoyo JL, Singhal B, Blanco Y, Hughes S, Garber J, Solaro C, McGuigan C, Taylor B, de Gans K, Habek M, Al-Asmi A, Mihaela S, Castillo Triviño T, Al-Harbi T, Rojas JI, Gray O, Khurana D, Van Wijmeersch B, Grigoriadis N, Inshasi J, Oh J, Aguera-Morales E, Fragoso Y, Moore F, Shaw C, Baghbanian SM, Shuey N, Willekens B, Hardy TA, Decoo D, Sempere AP, Field D, Wynford-Thomas R, Cunniffe NG, Roos I, Malpas CB, Coles AJ, Kalincik T, Brown JWL. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis. Mult Scler. 2023 Jun;29(7):875-883. doi: 10.1177/13524585231151951. Epub 2023 Feb 27.
Diouf I, Malpas CB, Sharmin S, Roos I, Horakova D, Havrdova EK, Patti F, Shaygannejad V, Ozakbas S, Izquierdo G, Eichau S, Onofrj M, Lugaresi A, Alroughani R, Prat A, Girard M, Duquette P, Terzi M, Boz C, Grand'Maison F, Hamdy S, Sola P, Ferraro D, Grammond P, Turkoglu R, Buzzard K, Skibina O, Yamout B, Altintas A, Gerlach O, van Pesch V, Blanco Y, Maimone D, Lechner-Scott J, Bergamaschi R, Karabudak R, Iuliano G, McGuigan C, Cartechini E, Barnett M, Hughes S, Sa MJ, Solaro C, Kappos L, Ramo-Tello C, Cristiano E, Hodgkinson S, Spitaleri D, Soysal A, Petersen T, Slee M, Butler E, Granella F, de Gans K, McCombe P, Ampapa R, Van Wijmeersch B, van der Walt A, Butzkueven H, Prevost J, Sinnige LGF, Sanchez-Menoyo JL, Vucic S, Laureys G, Van Hijfte L, Khurana D, Macdonell R, Gouider R, Castillo-Triviño T, Gray O, Aguera-Morales E, Al-Asmi A, Shaw C, Deri N, Al-Harbi T, Fragoso Y, Csepany T, Perez Sempere A, Trevino-Frenk I, Schepel J, Moore F, Kalincik T. Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis. Eur J Neurol. 2023 Apr;30(4):1014-1024. doi: 10.1111/ene.15706. Epub 2023 Feb 16.
Dunkerton S, Clarke AJ, Thompson EO, Xie P, Tisch S, Worthington JM, Azadi A, Halmagyi GM. Wilson Disease: A Case Report of Psychosis Preceding Parkinsonism. Am J Case Rep. 2023 Aug 16;24:e940561. doi: 10.12659/AJCR.940561.
Dunkerton S, Penninkilampi R, Beadnall H, Fulham M, Colebatch A, Jankelowitz S, Ahmed R, Thayer Z, Halmagyi M, Abadir E. Erdheim-Chester disease presenting as precipitous cognitive decline. Pract Neurol. 2023 Feb;23(1):91-92. doi: 10.1136/pn-2022-003504. Epub 2022 Oct 25.
Farrar MA, Kiernan MC, Kariyawasam DS. Presymptomatic spinal muscular atrophy: a cautionary approach to the proposed new terminology. Brain. 2023 Sep 1;146(9):e65-e66. doi: 10.1093/brain/awad061.
Gold R, Barnett M, Chan A, Feng H, Fujihara K, Giovannoni G, Montalbán X, Shi FD, Tintoré M, Xue Q, Yang C, Zhou H. Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method. Ther Adv Neurol Disord. 2023 Jul 14;16:17562864231180734. doi: 10.1177/17562864231180734.
Govender S, Biswas RK, Welgampola MS, Rosengren SM. Magnitude, variability and symmetry in head acceleration and jerk and their relationship to cervical and ocular vestibular evoked myogenic potentials. J Vestib Res. 2023;33(5):325-338. doi: 10.3233/VES-230008.
Gressie K, Kumfor F, Teng H, Foxe D, Devenney E, Ahmed RM, Piguet O. Error profiles of facial emotion recognition in frontotemporal dementia and Alzheimer's disease. Int Psychogeriatr. 2023 Apr 11:1-10. doi: 10.1017/S1041610223000297. Epub ahead of print.
Halliday AJ, Vogrin S, Ignatiadis S, Gillinder L, Jones D, Kiley M, Kwan P, Seneviratne U, Somerville E, Whitham E; Australian Comprehensive Epilepsy Centres Consortium. The efficacy and tolerability of adjunctive brivaracetam for the treatment of adult epilepsy: An Australian multi-center retrospective real-world observational cohort study. Epilepsy Behav. 2023 Aug;145:109287. doi: 10.1016/j.yebeh.2023.109287. Epub 2023 Jun 17.
Halmágyi GM, Akdal G, Welgampola MS, Wang C. Neurological update: neuro-otology 2023. J Neurol. 2023 Dec;270(12):6170-6192. doi: 10.1007/s00415-023-11922-9. Epub 2023 Aug 17.
Halmagyi GM, Parker GD, Chen L, Welgampola MS, Watson JDG, Barnett MH, Todd MJ, El-Wahsh S, Rose V, Stoodley MA, Brennan JW. Progressive loss of hearing and balance in superficial siderosis due to occult spinal dural defects. Eur Arch Otorhinolaryngol. 2023 Feb;280(2):633-641. doi: 10.1007/s00405-022-07523-3. Epub 2022 Jul 16.
Hannigan IP, Nham B, Wang C, Rosengren SM, Kwok BYC, McGarvie LA, Reid NM, Curthoys IS, Halmágyi GM, Welgampola MS. The Relationship between the Subjective Visual Horizontal and Ocular Vestibular Evoked Myogenic Potentials in Acute Vestibular Neuritis. Otol Neurotol. 2023 Jul 1;44(6):e419-e427. doi: 10.1097/MAO.0000000000003909. Epub 2023 May 31.
Harding IH, Ryan J, Heritier S, Spark S, Flanagan Z, McIntyre R, Anderson CS, Naismith SL, Chong TT, O'Sullivan M, Egan G, Law M, Zoungas S. STAREE-Mind Imaging Study: a randomised placebo-controlled trial of atorvastatin for prevention of cerebrovascular decline and neurodegeneration in older individuals. BMJ Neurol Open. 2023 Oct 31;5(2):e000541. doi: 10.1136/bmjno-2023-000541.
Harding-Forrester S, Roos I, Nguyen AL, Malpas CB, Diouf I, Moradi N, Sharmin S, Izquierdo G, Eichau S, Patti F, Horakova D, Kubala Havrdova E, Prat A, Girard M, Duquette P, Grand'Maison F, Onofrj M, Lugaresi A, Grammond P, Ozakbas S, Amato MP, Gerlach O, Sola P, Ferraro D, Buzzard K, Skibina O, Lechner-Scott J, Alroughani R, Boz C, Van Pesch V, Cartechini E, Terzi M, Maimone D, Ramo-Tello C, Yamout B, Khoury SJ, La Spitaleri D, Sa MJ, Blanco Y, Granella F, Slee M, Butler E, Sidhom Y, Gouider R, Bergamaschi R, Karabudak R, Ampapa R, Sánchez-Menoyo JL, Prevost J, Castillo-Trivino T, McCombe PA, Macdonell R, Laureys G, Van Hijfte L, Oh J, Altintas A, de Gans K, Turkoglu R, van der Walt A, Butzkueven H, Vucic S, Barnett M, Cristiano E, Hodgkinson S, Iuliano G, Kappos L, Kuhle J, Shaygannejad V, Soysal A, Weinstock-Guttman B, Van Wijmeersch B, Kalincik T; MSBase investigators. Disability accrual in primary and secondary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry. 2023 Sep;94(9):707-717. doi: 10.1136/jnnp-2022-330726. Epub 2023 Apr 17.
Hartung HP, Cree BAC, Barnett M, Meuth SG, Bar-Or A, Steinman L. Bioavailable central nervous system disease-modifying therapies for multiple sclerosis. Front Immunol. 2023 Nov 29;14:1290666. doi: 10.3389/fimmu.2023.1290666.
Hazelton JL, Devenney E, Ahmed R, Burrell J, Hwang Y, Piguet O, Kumfor F. Hemispheric contributions toward interoception and emotion recognition in left-vs right-semantic dementia. Neuropsychologia. 2023 Sep 9;188:108628. doi: 10.1016/j.neuropsychologia.2023.108628. Epub 2023 Jun 20.
Herbozo Contreras LF, Truong ND, Eshraghian JK, Xu Z, Huang Z, Nikpour A, Kavehei O. Neuromorphic Neuromodulation: Towards the next generation of on-device AI-revolution in electroceuticals. arXiv e-prints: arXiv: 2307.12471. 2023.
Hutchinson K, Ryder T, Coleman H, Nullwala R, Herkes G, Bleasel A, Nikpour A, Wong C, Todd L, Ireland C, Shears G, Bartley M, Groot W, Kerr M, Vagholkar S, Braithwaite J, Rapport F. Determining the role and responsibilities of the community epilepsy nurse in the management of epilepsy. J Clin Nurs. 2023 Jul;32(13-14):3730-3745. doi: 10.1111/jocn.16582. Epub 2022 Dec 9.
Jiang C, Li S, Wang Y, Lai Y, Bai Y, Zhao M, He L, Kong Y, Guo X, Li S, Liu N, Jiang C, Tang R, Sang C, Long D, Du X, Dong J, Anderson CS, Ma C. Diastolic Blood Pressure and Intensive Blood Pressure Control on Cognitive Outcomes: Insights From the SPRINT MIND Trial. Hypertension. 2023 Mar;80(3):580-589. doi: 10.1161/HYPERTENSIONAHA.122.20112. Epub 2023 Jan 23.
Kiernan MC, Burke D, Tan RH. The lower motor neuron homunculus: function matters. Brain. 2023 Jun 1;146(6):e34-e35. doi: 10.1093/brain/awad021.
Klistorner S, Van der Walt A, Barnett MH, Butzkueven H, Kolbe S, Parratt J, Yiannikas C, Klistorner A. Choroid plexus volume is enlarged in clinically isolated syndrome patients with optic neuritis. Mult Scler. 2023 Apr;29(4-5):540-548. doi: 10.1177/13524585231157206. Epub 2023 Mar 6.
Krishnan D, Kiernan MC. Neurotoxic risks from over-the-counter vitamin supplements. Med J Aust. 2023 Apr 17;218(7):304-306. doi: 10.5694/mja2.51851. Epub 2023 Feb 13.
Kyle K, Maamary J, Jonker B, Peters J, Barnett Y, Barnett M, D'Souza A, Maller J, Wang C, Tisch S. Consistency is key: influence of skull density ratio distribution on the formation of clinically effective lesions and long-term tremor suppression following treatment with MR-guided focused ultrasound. J Neurosurg. 2023 Sep 1;140(3):648-656. doi: 10.3171/2023.6.JNS231153.
Kyle K, Maller J, Barnett Y, Jonker B, Barnett M, D'Souza A, Calamante F, Maamary J, Peters J, Wang C, Tisch S. Tremor suppression following treatment with MRgFUS: skull density ratio consistency and degree of posterior dentatorubrothalamic tract lesioning predicts long-term clinical outcomes in essential tremor. Front Neurol. 2023 Apr 25;14:1129430. doi: 10.3389/fneur.2023.1129430.
Li JXL, Wang X, Henry A, Anderson CS, Hammond N, Harris K, Liu H, Loffler K, Myburgh J, Pandian J, Smyth B, Venkatesh B, Carcel C, Woodward M. Sex differences in pain expressed by patients across diverse disease states: individual patient data meta-analysis of 33,957 participants in 10 randomized controlled trials. Pain. 2023 Aug 1;164(8):1666-1676. doi: 10.1097/j.pain.0000000000002884. Epub 2023 Mar 24.
Li S, Jiang C, Wang Y, Lai Y, Zhao M, Li Q, Bai Y, Dai W, Guo Q, He L, Guo X, Wang W, Li S, Liu N, Jiang C, Tang R, Sang C, Long D, Du X, Dong J, Anderson CS, Ma C. Systolic Blood Pressure Time in Target Range and Cognitive Outcomes: Insights From the SPRINT MIND Trial. Hypertension. 2023 Aug;80(8):1628-1636. doi: 10.1161/HYPERTENSIONAHA.122.20711. Epub 2023 May 11.
Li T, Kandula T, Cohn RJ, Kiernan MC, Park SB, Farrar MA. Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia. Clin Neurophysiol. 2023 Oct;154:157-168. doi: 10.1016/j.clinph.2023.08.002. Epub 2023 Aug 11.
Li T, Timmins HC, Trinh T, Mizrahi D, Harrison M, Horvath LG, Grimison P, Friedlander M, Kiernan MC, King MT, Rutherford C, Goldstein D, Park SB. Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important Changes. J Natl Compr Canc Netw. 2023 Feb;21(2):125-132.e3. doi: 10.6004/jnccn.2022.7074.
Lin L, Blair C, Fu J, Cordato D, Cappelen-Smith C, Cheung A, Manning NW, Wenderoth J, Chen C, Bivard A, Butcher K, Kleinig TJ, Choi P, Levi CR, Parsons M; INSPIRE study group. Prior anticoagulation and bridging thrombolysis improve outcomes in patients with atrial fibrillation undergoing endovascular thrombectomy for anterior circulation stroke. J Neurointerv Surg. 2023 Dec 21;15(e3):e433-e437. doi: 10.1136/jnis-2022-019560.
Liu C, Ma Y, Kothur K, Nikpour A, Kavehei O. BioSignal Copilot: Leveraging the power of LLMs in drafting reports for biomedical signals [Preprint]. medRxiv: 2023.06.28.23291916.
Liu D, Cabezas M, Wang D, Tang Z, Bai L, Zhan G, Luo Y, Kyle K, Ly L, Yu J, Shieh CC, Nguyen A, Kandasamy Karuppiah E, Sullivan R, Calamante F, Barnett M, Ouyang W, Cai W, Wang C. Multiple sclerosis lesion segmentation: revisiting weighting mechanisms for federated learning. Front Neurosci. 2023 May 18;17:1167612. doi: 10.3389/fnins.2023.1167612.
Liu R, Du X, Patel A, Di Tanna GL, Zhao Y, Wang Z, Fan Y, Zhang H, Yi Y, Dong J, Anderson C, Liu H. Cluster randomized trial of influenza vaccination in patients with acute heart failure in China: A mixed-methods feasibility study. PLOS Glob Public Health. 2023 Jun 16;3(6):e0001947. doi: 10.1371/journal.pgph.0001947.
Ma L, Hu X, Song L, Chen X, Ouyang M, Billot L, Li Q, Malavera A, Li X, Muñoz-Venturelli P, de Silva A, Thang NH, Wahab KW, Pandian JD, Wasay M, Pontes-Neto OM, Abanto C, Arauz A, Shi H, Tang G, Zhu S, She X, Liu L, Sakamoto Y, You S, Han Q, Crutzen B, Cheung E, Li Y, Wang X, Chen C, Liu F, Zhao Y, Li H, Liu Y, Jiang Y, Chen L, Wu B, Liu M, Xu J, You C, Anderson CS; INTERACT3 Investigators. The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial. Lancet. 2023 Jul 1;402(10395):27-40. doi: 10.1016/S0140-6736(23)00806-1. Epub 2023 May 25. Erratum in: Lancet. 2023 Jul 15;402(10397):184. doi: 10.1016/S0140-6736(23)01420-4.
Ma Y, Liu C, Ma MS, Yang Y, Truong ND, Kothur K, Nikpour A, Kavehei O. Tsd: Transformers for seizure detection [Preprint]. bioRxiv: 2023.01.24.525308.
Maher C, Tang Z, D'Souza A, Cabezas M, Cai W, Barnett M, Kavehei O, Wang C, Nikpour A. Deep learning distinguishes connectomes from focal epilepsy patients and controls: feasibility and clinical implications. Brain Commun. 2023 Oct 31;5(6):fcad294. doi: 10.1093/braincomms/fcad294.
Maher C, Yang Y, Truong ND, Wang C, Nikpour A, Kavehei O. Seizure detection with reduced electroencephalogram channels: research trends and outlook. R Soc Open Sci. 2023 May 3;10(5):230022. doi: 10.1098/rsos.230022.
Marshall NS, Cho G, Toelle BG, Tonin R, Bartlett DJ, D'Rozario AL, Evans CA, Cowie CT, Janev O, Whitfeld CR, Glozier N, Walker BE, Killick R, Welgampola MS, Phillips CL, Marks GB, Grunstein RR. The Health Effects of 72 Hours of Simulated Wind Turbine Infrasound: A Double-Blind Randomized Crossover Study in Noise-Sensitive, Healthy Adults. Environ Health Perspect. 2023 Mar;131(3):37012. doi: 10.1289/EHP10757. Epub 2023 Mar 22.
Martinez-Valdes E, Enoka RM, Holobar A, McGill K, Farina D, Besomi M, Hug F, Falla D, Carson RG, Clancy EA, Disselhorst-Klug C, van Dieën JH, Tucker K, Gandevia S, Lowery M, Søgaard K, Besier T, Merletti R, Kiernan MC, Rothwell JC, Perreault E, Hodges PW. Consensus for experimental design in electromyography (CEDE) project: Single motor unit matrix. J Electromyogr Kinesiol. 2023 Feb;68:102726. doi: 10.1016/j.jelekin.2022.102726. Epub 2022 Nov 28.
Matar E, Bhatia K. Dystonia and Parkinson's disease: Do they have a shared biology? Int Rev Neurobiol. 2023;169:347-411. doi: 10.1016/bs.irn.2023.05.001. Epub 2023 May 30.
Matar E, Sanders RD. 'Where there's smoke': longitudinal cognitive disintegration after postoperative delirium? Br J Anaesth. 2023 Jul;131(1):1-5. doi: 10.1016/j.bja.2023.02.025. Epub 2023 Mar 27.
Mazumder S, McCann H, D'Silva S, Furlong S, Shepherd CE, Kril JJ, Halliday GM, Rowe DB, Kiernan MC, Tan RH. Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis. Brain. 2023 Mar 1;146(3):e17-e19. doi: 10.1093/brain/awac467.
Menon P, Pavey N, Aberra AS, van den Bos MAJ, Wang R, Kiernan MC, Peterchev AV, Vucic S. Dependence of cortical neuronal strength-duration properties on TMS pulse shape. Clin Neurophysiol. 2023 Jun;150:106-118. doi: 10.1016/j.clinph.2023.03.012. Epub 2023 Mar 30.
Nagaratnam SA, Edwards L, Blair C, Evans J, O'Brien W. Functional outcomes of patients with ischaemic stroke with known atrial fibrillation not on therapeutic anticoagulation. Intern Med J. 2023 Nov;53(11):1987-1993. doi: 10.1111/imj.16044. Epub 2023 Mar 20.
Nam HS, Kim YD, Heo J, Lee H, Jung JW, Choi JK, Lee IH, Lim IH, Hong SH, Baik M, Kim BM, Kim DJ, Shin NY, Cho BH, Ahn SH, Park H, Sohn SI, Hong JH, Song TJ, Chang Y, Kim GS, Seo KD, Lee K, Chang JY, Seo JH, Lee S, Baek JH, Cho HJ, Shin DH, Kim J, Yoo J, Lee KY, Jung YH, Hwang YH, Kim CK, Kim JG, Lee CJ, Park S, Lee HS, Kwon SU, Bang OY, Anderson CS, Heo JH; OPTIMAL-BP Trial Investigators. Intensive vs Conventional Blood Pressure Lowering After Endovascular Thrombectomy in Acute Ischemic Stroke: The OPTIMAL-BP Randomized Clinical Trial. JAMA. 2023 Sep 5;330(9):832-842. doi: 10.1001/jama.2023.14590.
Nham B, Akdal G, Young AS, Özçelik P, Tanrıverdizade T, Ala RT, Bradshaw AP, Wang C, Men S, Giarola BF, Black DA, Thompson EO, Halmagyi GM, Welgampola MS. Capturing nystagmus in the emergency room: posterior circulation stroke versus acute vestibular neuritis. J Neurol. 2023 Feb;270(2):632-641. doi: 10.1007/s00415-022-11202-y. Epub 2022 Jul 18.
Nham B, Wang C, Reid N, Calic Z, Kwok BYC, Black DA, Bradshaw A, Halmagyi G, Welgampola MS. Modern vestibular tests can accurately separate stroke and vestibular neuritis. J Neurol. 2023 Apr;270(4):2031-2041. doi: 10.1007/s00415-022-11473-5. Epub 2022 Dec 24.
Nuñez M, Delfino C, Asenjo-Lobos C, Schilling A, Lavados P, Anderson CS, Muñoz Venturelli P. Disparities in Stroke Incidence Over Time by Sex and Age in Latin America and the Caribbean Region 1997 to 2021: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2023 Sep 5;12(17):e029800. doi: 10.1161/JAHA.123.029800. Epub 2023 Aug 29.
Ouchida S, Nikpour A, Zhang X, Faulkner H, Senturias M, Reid N, Stephens E, Fairbrother G. The long-term outcomes of patients with negative prolonged ambulatory electroencephalography tests: A cross-sectional follow-up study. Health Open Res. 2023 Aug 10;5:26. doi: 10.12688/healthopenres.13351.1.
Ouyang M, Faigle R, Wang X, Johnson B, Summers D, Khatri P, Billot L, Liu H, Malavera A, Munoz-Venturelli P, Gonzalez F, Urrutia F, Day D, Song L, Sui Y, Delcourt C, Robinson T, Durham AC, Ebraimo A, Wan Zaidi WA, Jan S, Lindley RI, Urrutia VC, Anderson CS. The main Optimal Post rTpa-Iv Monitoring in Ischemic Stroke Trial (OPTIMISTmain): protocol for a pragmatic, stepped wedge, cluster randomized controlled trial. Cerebrovasc Dis. 2023 Oct 26. doi: 10.1159/000534706. Epub ahead of print.
Pan Y, Meng X, Yuan B, Johnston SC, Li H, Bath PM, Dong Q, Xu A, Jing J, Lin J, Jiang Y, Xie X, Jin A, Suo Y, Yang H, Feng Y, Zhou Y, Liu Q, Li X, Liu B, Zhu H, Zhao J, Huang X, Li H, Xiong Y, Li Z, Wang Y, Zhao X, Liu L, Wang Y; INSURE Investigators. Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE): a randomised, double-blind, double-dummy, active control, non-inferiority trial. Lancet Neurol. 2023 Jun;22(6):485-493. doi: 10.1016/S1474-4422(23)00113-8. Epub 2023 Apr 27.
Pavey N, Hannaford A, Higashihara M, van den Bos M, Kiernan MC, Menon P, Vucic S. Utility of split hand index with different motor unit number estimation techniques in ALS. Clin Neurophysiol. 2023 Dec;156:175-182. doi: 10.1016/j.clinph.2023.09.018. Epub 2023 Oct 26.
Pavey N, Menon P, van den Bos MAJ, Kiernan MC, Vucic S. Cortical inhibition and facilitation are mediated by distinct physiological processes. Neurosci Lett. 2023 Apr 23;803:137191. doi: 10.1016/j.neulet.2023.137191. Epub 2023 Mar 15.
Petrides GA, Hayler R, Lee JW, Jankelowitz S, Low TH. Electromyography in the prognostication of recovery in patients with acute peripheral facial nerve palsy: A systematic review. Clin Otolaryngol. 2023 Jul;48(4):563-575. doi: 10.1111/coa.14072. Epub 2023 Apr 28.
Pettigrew S, Santos JA, Li Y, Jun M, Anderson C, Jones A. Short report: Factors contributing to young people's susceptibility to e-cigarettes in four countries. Drug Alcohol Depend. 2023 Sep 1;250:109944. doi: 10.1016/j.drugalcdep.2023.109944. Epub 2023 Jun 13.
Pettigrew S, Santos JA, Li Y, Miller M, Anderson C, Raj TS, Jones A. E-cigarette-related beliefs, behaviors, and policy support among young people in China. Tob Induc Dis. 2023 Jan 23;21:09. doi: 10.18332/tid/156836.
Pinkerton M, Lourenco G, Pacheco MT, Halliday GM, Kiernan MC, Tan RH. Survival in sporadic ALS is associated with lower p62 burden in the spinal cord. J Neuropathol Exp Neurol. 2023 Aug 21;82(9):769-773. doi: 10.1093/jnen/nlad051.
Pittock SJ, Barnett M, Bennett JL, Berthele A, de Sèze J, Levy M, Nakashima I, Oreja-Guevara C, Palace J, Paul F, Pozzilli C, Yountz M, Allen K, Mashhoon Y, Kim HJ. Ravulizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder. Ann Neurol. 2023 Jun;93(6):1053-1068. doi: 10.1002/ana.26626. Epub 2023 Apr 5.
Rahayel S, Tremblay C, Vo A, Misic B, Lehéricy S, Arnulf I, Vidailhet M, Corvol JC; ICEBERG Study Group; Gagnon JF, Postuma RB, Montplaisir J, Lewis S, Matar E, Ehgoetz Martens K, Borghammer P, Knudsen K, Hansen AK, Monchi O, Gan-Or Z, Dagher A; Alzheimer’s Disease Neuroimaging Initiative. Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies. Brain. 2023 Aug 1;146(8):3301-3318. doi: 10.1093/brain/awad044.
Ramanan S, El-Omar H, Roquet D, Ahmed RM, Hodges JR, Piguet O, Lambon Ralph MA, Irish M. Mapping behavioural, cognitive and affective transdiagnostic dimensions in frontotemporal dementia. Brain Commun. 2023 Jan 5;5(1):fcac344. doi: 10.1093/braincomms/fcac344.
Roaldsen MB, Eltoft A, Wilsgaard T, Christensen H, Engelter ST, Indredavik B, Jatužis D, Karelis G, Kõrv J, Lundström E, Petersson J, Putaala J, Søyland MH, Tveiten A, Bivard A, Johnsen SH, Mazya MV, Werring DJ, Wu TY, De Marchis GM, Robinson TG, Mathiesen EB; TWIST Investigators. Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial. Lancet Neurol. 2023 Feb;22(2):117-126. doi: 10.1016/S1474-4422(22)00484-7. Epub 2022 Dec 19.
Roos I, Diouf I, Sharmin S, Horakova D, Havrdova EK, Patti F, Shaygannejad V, Ozakbas S, Izquierdo G, Eichau S, Onofrj M, Lugaresi A, Alroughani R, Prat A, Girard M, Duquette P, Terzi M, Boz C, Grand'Maison F, Sola P, Ferraro D, Grammond P, Turkoglu R, Buzzard K, Skibina O, Yamou B, Altintas A, Gerlach O, van Pesch V, Blanco Y, Maimone D, Lechner-Scott J, Bergamaschi R, Karabudak R, McGuigan C, Cartechini E, Barnett M, Hughes S, Sa MJ, Solaro C, Ramo-Tello C, Hodgkinson S, Spitaleri D, Soysal A, Petersen T, Granella F, de Gans K, McCombe P, Ampapa R, Van Wijmeersch B, van der Walt A, Butzkueven H, Prevost J, Sanchez-Menoyo JL, Laureys G, Gouider R, Castillo-Triviño T, Gray O, Aguera-Morales E, Al-Asmi A, Shaw C, Deri N, Al-Harbi T, Fragoso Y, Csepany T, Sempere AP, Trevino-Frenk I, Schepel J, Moore F, Malpas C, Kalincik T. Comparative effectiveness in multiple sclerosis: A methodological comparison. Mult Scler. 2023 Mar;29(3):326-332. doi: 10.1177/13524585231151394. Epub 2023 Feb 19.
Sánchez-de-la-Torre M, Gracia-Lavedan E, Benitez ID, Sánchez-de-la-Torre A, Moncusí-Moix A, Torres G, Loffler K, Woodman R, Adams R, Labarca G, Dreyse J, Eulenburg C, Thunström E, Glantz H, Peker Y, Anderson C, McEvoy D, Barbé F. Adherence to CPAP Treatment and the Risk of Recurrent Cardiovascular Events: A Meta-Analysis. JAMA. 2023 Oct 3;330(13):1255-1265. doi: 10.1001/jama.2023.17465.
Sharmin S, Roos I, Simpson-Yap S, Malpas C, Sánchez MM, Ozakbas S, Horakova D, Havrdova EK, Patti F, Alroughani R, Izquierdo G, Eichau S, Boz C, Zakaria M, Onofrj M, Lugaresi A, Weinstock-Guttman B, Prat A, Girard M, Duquette P, Terzi M, Amato MP, Karabudak R, Grand'Maison F, Khoury SJ, Grammond P, Lechner-Scott J, Buzzard K, Skibina O, van der Walt A, Butzkueven H, Turkoglu R, Altintas A, Maimone D, Kermode A, Shalaby N, Pesch VV, Butler E, Sidhom Y, Gouider R, Mrabet S, Gerlach O, Soysal A, Barnett M, Kuhle J, Hughes S, Sa MJ, Hodgkinson S, Oreja-Guevara C, Ampapa R, Petersen T, Ramo-Tello C, Spitaleri D, McCombe P, Taylor B, Prevost J, Foschi M, Slee M, McGuigan C, Laureys G, Hijfte LV, de Gans K, Solaro C, Oh J, Macdonell R, Aguera-Morales E, Singhal B, Gray O, Garber J, Wijmeersch BV, Simu M, Castillo-Triviño T, Sanchez-Menoyo JL, Khurana D, Al-Asmi A, Al-Harbi T, Deri N, Fragoso Y, Lalive PH, Sinnige LGF, Shaw C, Shuey N, Csepany T, Sempere AP, Moore F, Decoo D, Willekens B, Gobbi C, Massey J, Hardy T, Parratt J, Kalincik T. The risk of secondary progressive multiple sclerosis is geographically determined but modifiable. Brain. 2023 Nov 2;146(11):4633-4644. doi: 10.1093/brain/awad218.
Shimatani Y, Lin CS, Matamala JM, Kiernan MC. Strength-duration properties and excitability of motor and sensory axons across different target thresholds. J Neurophysiol. 2023 Jun 1;129(6):1434-1446. doi: 10.1152/jn.00456.2022. Epub 2023 May 10.
Silsby M, Fois AF, Yiannikas C, Ng K, Kiernan MC, Fung VSC, Vucic S. Chronic inflammatory demyelinating polyradiculoneuropathy-associated tremor: Phenotype and pathogenesis. Eur J Neurol. 2023 Apr;30(4):1059-1068. doi: 10.1111/ene.15693. Epub 2023 Feb 12.
Silsby M, Yiannikas C, Fois AF, Ng K, Kiernan MC, Fung VSC, Vucic S. Imbalance and lower limb tremor in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst. 2023 Sep;28(3):415-424. doi: 10.1111/jns.12574. Epub 2023 Jun 21. 
Sun J, Lam C, Christie L, Blair C, Li X, Werdiger F, Yang Q, Bivard A, Lin L, Parsons M. Risk factors of hemorrhagic transformation in acute ischaemic stroke: A systematic review and meta-analysis. Front Neurol. 2023 Feb 20;14:1079205. doi: 10.3389/fneur.2023.1079205.
Tan RH, McCann H, Shepherd CE, Pinkerton M, Mazumder S, Devenney EM, Adler GL, Rowe DB, Kril J, Halliday GM, Kiernan MC. Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2023 Nov 13;11(1):180. doi: 10.1186/s40478-023-01670-2.
Tang Z, Chen S, D'Souza A, Liu D, Calamante F, Barnett M, Cai W, Wang C, Cabezas M. High angular diffusion tensor imaging estimation from minimal evenly distributed diffusion gradient directions. Front Radiol. 2023 Sep 11;3:1238566. doi: 10.3389/fradi.2023.1238566.
Timmins HC, Vucic S, Kiernan MC. Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis. Curr Opin Neurol. 2023 Aug 1;36(4):353-359. doi: 10.1097/WCO.0000000000001162. Epub 2023 May 24.
Todd G, Rae CD, Taylor JL, Rogasch NC, Butler JE, Hayes M, Wilcox RA, Gandevia SC, Aoun K, Esterman A, Lewis SJG, Hall JM, Matar E, Godau J, Berg D, Plewnia C, von Thaler AK, Chiang C, Double KL. Motor cortical excitability and pre-supplementary motor area neurochemistry in healthy adults with substantia nigra hyperechogenicity. J Neurosci Res. 2023 Feb;101(2):263-277. doi: 10.1002/jnr.25145. Epub 2022 Nov 10.
Trotman J, Presgrave P, Carradice DP, Lenton DS, Gandhi MK, Cochrane T, Badoux X, Carlson J, Nkhoma G, Butcher B, Nikpour A, Fulham M, Johnston AM. Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive After Treatment for Relapsed Follicular Lymphoma: A Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study. Hemasphere. 2023 Feb 21;7(3):e836. doi: 10.1097/HS9.0000000000000836.
Tse NY, Bocchetta M, Todd EG, Devenney EM, Tu S, Caga J, Hodges JR, Halliday GM, Irish M, Kiernan MC, Piguet O, Rohrer JD, Ahmed RM. Distinct hypothalamic involvement in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum. Neuroimage Clin. 2023;37:103281. doi: 10.1016/j.nicl.2022.103281. Epub 2022 Dec 6.
Tuft C, Matar E, Menczel Schrire Z, Grunstein RR, Yee BJ, Hoyos CM. Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults. Clin Interv Aging. 2023 Jan 12;18:49-59. doi: 10.2147/CIA.S361519.
Vucic S, Kiernan MC. Nanocrystalline gold (CNM-Au8): a novel bioenergetic treatment for ALS. Expert Opin Investig Drugs. 2023 Jul-Dec;32(9):783-785. doi: 10.1080/13543784.2023.2263368. Epub 2023 Oct 13.
Vucic S, Menon P, Huynh W, Mahoney C, Ho KS, Hartford A, Rynders A, Evan J, Evan J, Ligozio S, Glanzman R, Hotchkin MT, Kiernan MC. Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension. EClinicalMedicine. 2023 Jun 8;60:102036. doi: 10.1016/j.eclinm.2023.102036. 
Vucic S, Stanley Chen KH, Kiernan MC, Hallett M, Benninger DH, Di Lazzaro V, Rossini PM, Benussi A, Berardelli A, Currà A, Krieg SM, Lefaucheur JP, Long Lo Y, Macdonell RA, Massimini M, Rosanova M, Picht T, Stinear CM, Paulus W, Ugawa Y, Ziemann U, Chen R. Clinical diagnostic utility of transcranial magnetic stimulation in neurological disorders. Updated report of an IFCN committee. Clin Neurophysiol. 2023 Jun;150:131-175. doi: 10.1016/j.clinph.2023.03.010. Epub 2023 Mar 29.
Wang D, Jin R, Shieh CC, Ng AY, Pham H, Dugal T, Barnett M, Winoto L, Wang C, Barnett Y. Real world validation of an AI-based CT hemorrhage detection tool. Front Neurol. 2023 Aug 3;14:1177723. doi: 10.3389/fneur.2023.1177723.
Wang Z, Du X, Hua C, Li W, Zhang H, Liu X, Wang Y, Jiang C, Guo J, Lv Q, Anderson CS, Dong J, Ma C. The Effect of Frailty on the Efficacy and Safety of Intensive Blood Pressure Control: A Post Hoc Analysis of the SPRINT Trial. Circulation. 2023 Aug 15;148(7):565-574. doi: 10.1161/CIRCULATIONAHA.123.064003. Epub 2023 Jul 4.
Willemse SW, Harley P, van Eijk RPA, Demaegd KC, Zelina P, Pasterkamp RJ, van Damme P, Ingre C, van Rheenen W, Veldink JH, Kiernan MC, Al-Chalabi A, van den Berg LH, Fratta P, van Es MA. UNC13A in amyotrophic lateral sclerosis: from genetic association to therapeutic target. J Neurol Neurosurg Psychiatry. 2023 Aug;94(8):649-656. doi: 10.1136/jnnp-2022-330504. Epub 2023 Feb 3.
Wu S, Wang Y, Yuan R, Guo F, Yang D, Li Z, Wu B, Wang C, Duan J, Ling T, Zhang H, Zhang S, Wu B, Anderson CS, Liu M. Predicting the emergence of malignant brain oedema in acute ischaemic stroke: a prospective multicentre study with development and validation of predictive modelling. EClinicalMedicine. 2023 Apr 27;59:101977. doi: 10.1016/j.eclinm.2023.101977.
Xu Y, Phu J, Aung HL, Hesam-Shariati N, Keay L, Tully PJ, Booth A, Anderson CS, Anstey KJ, Peters R. Frequency of coexistent eye diseases and cognitive impairment or dementia: a systematic review and meta-analysis. Eye (Lond). 2023 Oct;37(15):3128-3136. doi: 10.1038/s41433-023-02481-4. Epub 2023 Mar 15.
Xu Z, Truong ND, Nikpour A, Kavehei O. A miniaturized and low-energy subcutaneous optical telemetry module for neurotechnology. J Neural Eng. 2023 May 22;20(3). doi: 10.1088/1741-2552/acd147.
Yang Y, Eshraghian JK, Truong ND, Nikpour A, Kavehei O. Neuromorphic deep spiking neural networks for seizure detection. Neuromorphic Computing and Engineering. 2023. 3: 014010.
Yang Y, Rowe D, McCann H, Shepherd CE, Kril JJ, Kiernan MC, Halliday GM, Tan RH. Treatment with the copper compound CuATSM has no significant effect on motor neuronal pathology in patients with ALS. Neuropathol Appl Neurobiol. 2023 Aug;49(4):e12919. doi: 10.1111/nan.12919.
Zhan G, Wang D, Cabezas M, Bai L, Kyle K, Ouyang W, Barnett M, Wang C. Learning from pseudo-labels: deep networks improve consistency in longitudinal brain volume estimation. Front Neurosci. 2023 Jul 6;17:1196087. doi: 10.3389/fnins.2023.1196087.
Zhang S, Zhu C, Broocks G, Huang P, Blair C. Editorial: Neuroimaging study of post-stroke cerebral edema. Front Neurol. 2023 Mar 7;14:1167275. doi: 10.3389/fneur.2023.1167275.
Zhang X, Ahmed R, Thayer Z, Breen N, McMillan J, Fulham M, Nikpour A. Late-onset epilepsy with cognitive symptoms: Comparison of cognitive and imaging profiles with probable Alzheimer's disease. Epilepsy Behav. 2023 Sep;146:109371. doi: 10.1016/j.yebeh.2023.109371. Epub 2023 Aug 7.
Zhu C, Kalincik T, Horakova D, Zhou Z, Buzzard K, Skibina O, Alroughani R, Izquierdo G, Eichau S, Kuhle J, Patti F, Grand'Maison F, Hodgkinson S, Grammond P, Lechner-Scott J, Butler E, Prat A, Girard M, Duquette P, Macdonell RAL, Weinstock-Guttman B, Ozakbas S, Slee M, Sa MJ, Van Pesch V, Barnett M, Van Wijmeersch B, Gerlach O, Prevost J, Terzi M, Boz C, Laureys G, Van Hijfte L, Kermode AG, Garber J, Yamout B, Khoury SJ, Merlo D, Monif M, Jokubaitis V, van der Walt A, Butzkueven H; MSBase Study Group. Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation. JAMA Neurol. 2023 Jul 1;80(7):739-748. doi: 10.1001/jamaneurol.2023.1542.